Search Result "glucagon-like peptide 1 (GLP-1)"


Research Article

A Novel GLP-1R/fHCS Method to Determine the Bioactivity of Glucagon- Like Peptide 1(GLP-1) Analogous Drugs In Vitro

Journal: Current Pharmaceutical Analysis
Volume: 17 Issue: 9 Year: 2021 Page: 1197-1205
Author(s): Jie Wang,Ping Lu,Shengting Zhang,Wanwan Li,Xiuling Ji,Jing Li,Hui Zhang,Yunlin Wei,Chenggang Liang

Review Article

The Effects of Glucagon-Like Peptide Type 1 (GLP-1) and its Analogues in Adipose Tissue: Is there a way to Thermogenesis?

Journal: Current Molecular Medicine
Volume: 21 Issue: 7 Year: 2021 Page: 527-538
Author(s): Stafeev Iurii,Sorkina Ekaterina,Ekaterina Koksharova,Tumanyan Tatevik,Sklyanik Igor,Menshikov Mikhail,Mayorov Alexandr,Parfyonova Yelena,Shestakova Marina

Review Article

Drug Design of GLP-1 Receptor Agonists: Importance of In Silico Methods

Journal: Current Pharmaceutical Design
Volume: 27 Issue: 8 Year: 2021 Page: 1015-1024
Author(s): Smriti Sharma,Vinayak Bhatia

Review Article

Efficacy and Cardiovascular Safety of GLP-1 Receptor Analogues

Journal: Current Drug Safety
Volume: 16 Issue: 2 Year: 2021 Page: 197-206
Author(s): Anoop Mohamed Iqbal,Nasvin Imamudeen,Amjad Basheer,Sukrita Menon,Gisha Mohan,Tesil Nedumkallel Sani,Nisha Nigil Haroon

Review Article

Effects of Glucagon-like Peptide-1 Receptor Agonists and Sodium-glucose Cotransporter 2 Inhibitors on Cardiorenal and Metabolic Outcomes in People Without Diabetes

Journal: Current Pharmaceutical Design
Volume: 27 Issue: 8 Year: 2021 Page: 1035-1042
Author(s): Athanasia K. Papazafiropoulou,Andreas Melidonis,Stavros Antonopoulos

Review Article

Role of GLP-1 Analogs in the Management of Diabetes and its SecondaryComplication

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 21 Issue: 2 Year: 2021 Page: 3166-3182
Author(s): Ponnurengam Malliappan Sivakumar,B. Premkumar,Veluchamy Prabhawathi,Pranav Kumar Prabhakar

Review Article

Pharmacogenetics of the Glucagon-like Peptide-1 Receptor Agonist Liraglutide: A Step Towards Personalized Type 2 Diabetes Management

Journal: Current Pharmaceutical Design
Volume: 27 Issue: 8 Year: 2021 Page: 1025-1034
Author(s): Artemis Kyriakidou,Theocharis Koufakis,Dimitrios G. Goulis,Yiannis Vasilopoulos,Pantelis Zebekakis,Kalliopi Kotsa

Review Article

Cardio-protective Effects of Glucagon-like Peptide-1 Receptor Agonists: An Overview of Systematic Reviews and Publication Overlap

Journal: Current Pharmaceutical Design
Volume: 27 Issue: 8 Year: 2021 Page: 1068-1079
Author(s): Stefanos Zafeiropoulos,Areti Pagiantza,Ioannis Doundoulakis,Nikolaos Stalikas,Ioannis Farmakis,Athanasios Samaras,Christina Antza,George Giannakoulas

Research Article

Selar (Selar crumenophthalmus) Fish Protein Hydrolysate Has Antidiabetic Properties Possibly through GLP-1

Journal: Current Nutrition & Food Science
Volume: 17 Issue: 5 Year: 2021 Page: 516-522
Author(s): Rio J. Kusuma,Aviria Ermamilia,Salehah N. Halimah,Ninda F. Pradani,Imroatus Sholikha

Mini-Review Article

Deciphering the Neuroprotective Role of Glucagon-like Peptide-1 Agonists in Diabetic Neuropathy: Current Perspective and Future Directions

Journal: Current Protein & Peptide Science
Volume: 22 Issue: 1 Year: 2021 Page: 4-18
Author(s): Keshav Mehta,Tapan Behl,Arun Kumar,Md Sahab Uddin,Gokhan Zengin,Sandeep Arora

Previous   Next

Go To   Results 1 - 1 of 67

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy